Nevro Corp ( (NVRO) ) just unveiled an announcement. Nevro Corp. reported a better-than-expected worldwide revenue and adjusted EBITDA for Q3 ...

Nevro Corp. (NYSE:NVRO) just released its latest quarterly results and things are looking bullish. Results overall were solid, with revenues arriving 4.2% better than analyst forecasts at US$97m.

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...

Nevro's HFX iQ spinal cord stimulator earned the European Union's CE mark, the company said Nov. 12.

NVRO's third-quarter earnings beat its Zacks Consensus Estimate, while worldwide revenues decline year over year. The company ...

Nevro (NYSE:NVRO) announced today that it received CE mark in Europe for its HFX iQ spinal cord stimulation (SCS) system.

Q3 2024 Earnings Call Transcript November 11, 2024 Nevro Corp. beats earnings expectations. Reported EPS is $-0.51, ...

Baird reaffirms Nevro with a Neutral and raises the price target from $5 to $6. RBC Capital reiterates Nevro with a Sector ...

Piper Sandler analyst Adam Maeder assigned a Sell rating to Nevro Corp (NVRO – Research Report) today and set a price target of $6.00. The company’s shares closed yesterday at $5.32. Maeder covers the ...

Q3 2024 Earnings Conference Call November 11, 2024 4:30 PM ETCompany ParticipantsAngie McCabe - Vice President, Investor ...

The Redwood City, California-based company said it had a loss of 41 cents per share. Losses, adjusted for non-recurring gains, came to 51 cents per share. The results exceeded Wall Street expectations ...

Nevro (NYSE:NVRO) is scheduled to announce Q3 earnings results on Monday, November 11th, after market close. The consensus EPS Estimate is -$0.84 (-29.2% Y/Y) and the consensus Revenue Estimate is ...